Preserving Lung Function: The Holy Grail in Managing Cystic Fibrosis

Ann Am Thorac Soc. 2017 Jun;14(6):833-835. doi: 10.1513/AnnalsATS.201703-254ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Bacterial Agents
  • Child
  • Cystic Fibrosis*
  • Humans
  • Respiratory Physiological Phenomena

Substances

  • Anti-Bacterial Agents